ENFN - Enfusion - Stock Forecast

Technology - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Enfusion's activity chart (see below) currently has 61 price targets and 42 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48.6% with an average time for these price targets to be met of 76.33 days.

Most recent stock forecast was given by PARKER LANE from STIFEL on 04-Mar-2025. First documented stock forecast 15-Nov-2021.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 04-Mar-2025

$11.25

$0.49 (4.55%)

$11.25

1 years 7 months 22 days ago
(04-Mar-2025)

2/6 (33.33%)

$-0.15 (-1.32%)

21

Hold Since 03-Apr-2023

$11.5

$0.74 (6.88%)

$10

1 years 10 months 3 days ago
(23-Dec-2024)

5/5 (100%)

$0.98 (9.32%)

167

Sell Since 10-May-2023

$9

$-1.76 (-16.36%)

$10

2 years 7 months 13 days ago
(13-Mar-2024)

3/5 (60%)

$-0.32 (-3.43%)

74

Hold Since 15-Nov-2021

$8

$-2.76 (-25.65%)

$10

2 years 7 months 28 days ago
(28-Feb-2024)

6/7 (85.71%)

$-0.73 (-8.36%)

180

Sell Since 30-Jan-2024

$9

$-1.76 (-16.36%)

$12

2 years 8 months 26 days ago
(30-Jan-2024)

1/2 (50%)

$0.97 (12.08%)

17

Show more analysts

Please expand the browser size to see the chart

What is ENFN (Enfusion) average time for price targets to be met?

On average it took 76 days for the stock forecasts to be reached, with an average price target met ratio of 48.6%.

Which analyst most recently updated their price target on ENFN (Enfusion)?

Parker Lane

Which analyst has the most public recommendations on ENFN (Enfusion)?

Parker Lane works at STIFEL and has 29 price targets and 18 ratings on ENFN

Which analyst is the currently most bullish on ENFN (Enfusion)?

Parker Lane with the highest potential upside of $2.24

Which analyst is the currently most reserved on ENFN (Enfusion)?

Gabriela Borges with the lowest potential downside of -$2.76
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?